Kouwenhoven, Mathilde C M <br/><br/>
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Oct 2006 
 - 2499-503 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2006.05.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Brain Neoplasms--drug therapy<br/>Chromosomes, Human, Pair 1<br/>Chromosomes, Human, Pair 19<br/>Clinical Trials, Phase II as Topic<br/>Dacarbazine--analogs & derivatives<br/>Disease-Free Survival<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Multicenter Studies as Topic<br/>Neoplasm Recurrence, Local--drug therapy<br/>Oligodendroglioma--drug therapy<br/>Prospective Studies<br/>Salvage Therapy<br/>Survival Analysis<br/>Temozolomide<br/>Treatment Outcome